Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06597851

Insulin Resistance and Coronary Microvascular Dysfunction in Patients with Myocardial Ischemia and Non-obstructive Coronary Artery Disease

Led by Azienda Ospedaliera Universitaria Integrata Verona · Updated on 2024-09-19

40

Participants Needed

1

Research Sites

105 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this prospective study is to assess the correlation between coronary microvascular disfunction and insulin resistance in patients with INOCA. Patients with ANOCA and without diabetes will undergo invasive coronary microvascular assessment through coronary angiography and insulin resistance assessment through hyperinsulinemic-euglycemic clamp test. Patients enrolled in the study will be followed for a period of 2 years to monitor their clinical status.

CONDITIONS

Official Title

Insulin Resistance and Coronary Microvascular Dysfunction in Patients with Myocardial Ischemia and Non-obstructive Coronary Artery Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged over 18 years.
  • Cardiac chest pain with evidence of myocardial ischemia at noninvasive myocardial stress imaging and clinical indication to diagnostic coronary angiography
  • Willing and able to give informed consent for participation in the study
Not Eligible

You will not qualify if you...

  • Obstructive CAD (defined as more than 70% luminal stenosis and/or FFR 40.80 in 1 or more epicardial vessels).
  • History of previous myocardial infarction, percutaneous revascularization or coronary-aortic bypass graft (CABG) surgery.
  • Diagnosis of type II diabetes.
  • BMI 3 35 kg/m2.
  • Stage IV and V of chronic kidney disease (eGFR 4 30 ml/min, estimated through CKD - EPI Creatinine Equation).
  • Allergy or other contraindication to iodinated contrast and/or gadolinium and/or adenosine.
  • Chronic resting O2 saturation 4 85%.
  • Pregnancy or suspected pregnancy.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Azienda Ospedaliera Universitaria di Verona

Verona, VR, Italy, 37126

Actively Recruiting

Loading map...

Research Team

N

Natascia Antonioli

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here